Merit medical reports second quarter 2024 results and raises full-year guidance

Second quarter 2024 highlights† reported revenue of $338.0 million, up 5.6% constant currency revenue* up 6.6% constant currency revenue, organic,* up 5.0% gaap operating margin of 13.6%, compared to 9.0% in prior year period non-gaap operating margin* of 20.1%, compared to 19.1% in prior year period gaap eps $0.61, up 75.7% non-gaap eps* $0.92, up 16.8% † comparisons noted in the bullet points are calculated for the current quarter compared with the same prior year period unless otherwise specified. * the constant currency revenue; constant currency revenue, organic; non-gaap gross profit and margin; non-gaap operating income and margin; non-gaap net income; non-gaap eps; and free cash flow figures (used here and below) are non-gaap financial measures.
MMSI Ratings Summary
MMSI Quant Ranking